Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Consolidated Net Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,282 Cr₹1,433 Cr₹127 Cr₹10,304 Cr₹579 Cr

What is the latest Consolidated Net Profit of MANKIND PHARMA ?

The latest Consolidated Net Profit ratio of MANKIND PHARMA is ₹1,282 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹1,282 Cr
Mar2023₹1,433 Cr
Mar2022₹127 Cr
Mar2021₹10,304 Cr
Mar2020₹579 Cr

How is Consolidated Net Profit of MANKIND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹1,282 Cr
-10.58
Mar2023 ₹1,433 Cr
1,032.80
Mar2022 ₹127 Cr
-98.77
Mar2021 ₹10,304 Cr
1,681.10
Mar2020 ₹579 Cr -

Compare Consolidated Net Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,144.2 Cr 0.7% -6.7% 10.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,824.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,355.0 Cr 1.3% 10.7% 49.3% Stock Analytics
CIPLA ₹122,929.0 Cr 2.2% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,502.0 Cr 2% -0.8% 15.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.7%

-6.7%

10.3%

SENSEX

1.9%

0.1%

10.9%


You may also like the below Video Courses